Interesting as I was thinking of changing to Fiasp, when you say less potent do you mean your using more insulin using Fiasp as you were/are using Humalog? ( a bit confused as you mention the stacking effect and wonder if your referring to the action time of the insulin).
I'll tag the member @tim2000s into your thread as I'm sure he is using Fiasp in his pump.
Yes I seem to need 20-25% more units.
Were you on Humalog ?I have had no change in my I:c ratio moving to FIASP, the only thing that annoys me with it is that it has the same tail as nova in my opinion, which when bolusing closer to the meal vs waiting 20-40 mins, means the tail is still going round the duration that you saved by bolusing sooner.
However, FIASP has allowed me to eat Muesli again, I still have to wait 15-20 mins on this one even with FIASP but its working.
I think you'll get that and a shorter tail too.Right that's interesting @kzlorenz , due back to see Consultant in September so will ask a few more questions about Fiasp before deciding, reason for wanting to change was the quicker acting time over Novorapid (not having to pre-bolus too far ahead).
Much appreciated, thanksNova I was on but thought I would add my two cents as FIASP users are not commonplace at the moment.
Absolutlely not true. What it has is a different profile, so that more of the insulin is used by muscle up front, but the half life is the same as novorapid (about 57 minutes) which means the tail is as long, but not as intense. We've been trying to model it for artificial pancreas purposes and finding the relationship to be a little "awkward" between absorption and clearance.I think you'll get that and a shorter tail too.
@tim2000s do you have a reference for those graphs please?
Sent from my ONEPLUS A3003 using Diabetes.co.uk Forum mobile app
Shorter than Humalog in my case.Absolutlely not true. What it has is a different profile, so that more of the insulin is used by muscle up front, but the half life is the same as novorapid (about 57 minutes) which means the tail is as long, but not as intense. We've been trying to model it for artificial pancreas purposes and finding the relationship to be a little "awkward" between absorption and clearance.
We use cookies and similar technologies for the following purposes:
Do you accept cookies and these technologies?
We use cookies and similar technologies for the following purposes:
Do you accept cookies and these technologies?